Medication info
Memantine 10 mg (Memantine Hydrochloride)

Memantine 10 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Il Sung IS Co., Ltd.
Appearance
White rectangular film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202000854 · Approved 2020.02.12 · Insurance code 655404460

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer’s dementia, and only when a caregiver is available to regularly check that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient’s tolerability of treatment should be reassessed regularly. This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1–7): Administer 5mg once daily for 7 days. Week 2 (days 8–14): Administer 10mg once daily for 7 days. Week 3 (days 15–21): Administer 15mg once daily for 7 days. From week 4 onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose in older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-escalation regimen. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, administration of this medicine is preferably avoided.

Ingredients

Manufacturer
Il Sung IS Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

View approved original text

This medication helps alleviate memory decline and cognitive function deterioration in patients with moderate to severe Alzheimer's disease. It is used to improve the patient's ability to perform daily activities, thereby enhancing their quality of life.

How to take

Adult dose

Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer’s dementia, and only when a caregiver is available to regularly check that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient’s tolerability of treatment should be reassessed regularly. This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1–7): Administer 5mg once daily for 7 days. Week 2 (days 8–14): Administer 10mg once daily for 7 days. Week 3 (days 15–21): Administer 15mg once daily for 7 days. From week 4 onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose in older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-escalation regimen. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, administration of this medicine is preferably avoided.

Precautions

This medication should not be used by patients with hypersensitivity to the ingredient or those with severe liver or kidney dysfunction. Patients with epilepsy or a history of seizures, as well as those taking specific medications, should use with caution due to an increased risk of side effects. Various side effects can occur in different organ systems, including dizziness, headache, constipation, drowsiness, and hypertension, which can be relatively common. Since this medication may interact with other drugs, it is essential to consult with a doctor or pharmacist if taking other medications. Women who are pregnant or may become pregnant should carefully weigh the risks and benefits of using this medication, and it is advisable to discontinue breastfeeding if nursing. It is recommended not to use this medication in children or adolescents under 18 years of age, as its safety and efficacy have not been established. In case of overdose, central nervous system symptoms and gastrointestinal symptoms may occur, so immediate medical attention should be sought for appropriate treatment. This medication may affect reaction time and concentration, so caution is needed while driving or operating machinery. Finally, it is important to store this medication out of reach of children and not to transfer it to another container to ensure safety and maintain quality.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity
  • drowsiness
  • confusion
  • hallucination
Show 33 more
  • psychotic reaction
  • dizziness
  • balance disorder
  • gait abnormalities
  • seizure
  • heart failure
  • hypertension
  • venous thrombosis
  • thromboembolism
  • dyspnea
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver function tests
  • hepatitis
  • headache
  • fatigue
  • tiredness
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • anxiety
  • aggression
  • hallucination
  • gait disturbance
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • drowsiness
  • stupor
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is important to maintain a storage temperature between 1°C and 30°C at room temperature. This helps preserve the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White rectangular film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.